Infanrix

(Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed)

Infanrix

Drug updated on 10/23/2023

Dosage FormInjection (intramuscular: 0.5 mL)
Drug ClassVaccines
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the seventh birthday).

Product Monograph / Prescribing Information

Systematic Reviews / Meta-Analyses